Shalin Y. ShahCo-CEO / Interim CFO
Shalin has served as Chief Financial Officer of Marius Pharmaceuticals since the company formed in 2017. He is responsible for both financial oversight and helps drive company strategy, including pre-commercialization work around Marius’s lead asset, Kyzatrex™.
For the last decade Shalin has held roles focused on public and private investing globally. His experience ranges across sectors and company size. Shalin also has taken on operational roles and provided strategic feedback at Board Levels.